## **Core Concept**
Malignant hyperthermia (MH) is a life-threatening medical emergency that can be triggered by certain drugs used in general anesthesia. It is a pharmacogenetic disorder that results from mutations in genes encoding for **ryanodine receptors** or other components of the excitation-contraction coupling apparatus in skeletal muscle. The condition leads to an uncontrollable rise in body temperature, muscle rigidity, and metabolic acidosis.

## **Why the Correct Answer is Right**
Ketamine is an anesthetic agent that works by blocking **N-methyl-D-aspartate (NMDA) receptors**, which are involved in the regulation of glutamate, a neurotransmitter. Unlike volatile anesthetics and depolarizing muscle relaxants like succinylcholine, ketamine does not trigger malignant hyperthermia. This makes ketamine a safer choice in patients susceptible to MH.

## **Why Each Wrong Option is Incorrect**
* **Option A:** Halothane is a volatile anesthetic known to trigger malignant hyperthermia. Volatile anesthetics and ether derivatives can induce MH in susceptible individuals.
* **Option B:** Isoflurane, another volatile anesthetic, is also a known trigger for malignant hyperthermia. All volatile anesthetics carry this risk.
* **Option D:** Succinylcholine, a depolarizing muscle relaxant, can trigger malignant hyperthermia. It acts on nicotinic acetylcholine receptors to cause muscle depolarization.

## **Clinical Pearl / High-Yield Fact**
A key clinical pearl is that patients susceptible to malignant hyperthermia should avoid volatile anesthetics and succinylcholine. The **MH Hotline** (1-800-MH-HYPER) provides immediate consultation for managing suspected MH cases. Early recognition and treatment are critical.

## **Correct Answer:** . Ketamine